Type 1 Reaction in Patients With Leprosy Corresponds to a Decrease in Proresolving Lipid Mediators and an Increase in Proinflammatory Lipid Mediators

Silva, Carlos A. M.; Webb, Kristofor; Andre, Barbara G.; Marques, Maria Angela; Carvalho, Fernanda Marques; Macedo, Cristiana Santos de; Pinheiro, Roberta Olmo; Sarno, Euzenir Nunes; Pessolani, Maria Cristina Vidal; Belisle, John T..
Artículo en Inglés | ARCA | ID: arc-25185

Documentos relacionados

  1. Type 1 Reaction in Patients With Leprosy Corresponds to a Decrease in Proresolving Lipid Mediators and an Increase in Proinflammatory Lipid Mediators.
  2. Different profiles of chemokines, cytokines and cell growth factors in plasma samples from patients with leprosy, leprosy reactions and households contacts.
  3. Implications of Serum Anti-Ceramide Antibodies and Interleukin 4 on Nerve Damage and Physical Impairments Among Leprotic Patients: A Case-Controlled Study.
  4. Hyperfunction variant rs708035 of interleukin 1 receptor-associated kinases 2 gene involved in the predisposition of leprosy infection.
  5. Profile of oxidative stress in response to treatment for type 1 leprosy reaction.
  6. Mycobacterium leprae: Pathogenesis, diagnosis, and treatment options.
  7. Cyclosporin A as an Alternative Neuroimmune Strategy to Control Neurites and Recover Neuronal Tissues in Leprosy.
  8. Host Lipid Mediators in Leprosy: The Hypothesized Contributions to Pathogenesis.
  9. Leprosy Reactions: Experience in the Puerto Rico Hansen's Disease Population.
  10. Uncommon clinical presentations of leprosy: apropos of three cases.